Inventors:
Hong Liu - San Diego CA, US
Xiaohui He - San Diego CA, US
Dean Phillips - San Marcos CA, US
Xuefeng Zhu - Carlsbad CA, US
Kunyong Yang - San Diego CA, US
Thomas Lau - San Diego CA, US
Baogen Wu - San Diego CA, US
Yongping Xie - San Diego CA, US
Truc Ngoc Nguyen - San Diego CA, US
Xing Wang - San Diego CA, US
Assignee:
IRM LLC, A Delaware Limited Liability Company - Hamilton
International Classification:
A01N 43/50, A61K 31/415, A61K 31/50, A61K 31/501, A61K 31/497, C07D 401/00, C07D 233/00, C07D 233/02, C07D 241/00, C07D 241/02
US Classification:
514391, 514390, 5142521, 5462727, 5483001, 544336
Abstract:
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).